Scancell Holdings Plc (LON:SCLP) shares reached a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 6 ($0.08) and last traded at GBX 6.30 ($0.08), with a volume of 447173 shares changing hands. The stock had previously closed at GBX 6.60 ($0.09).
ILLEGAL ACTIVITY WARNING: This news story was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of US and international trademark & copyright law. The correct version of this news story can be accessed at https://www.com-unik.info/2019/02/11/scancell-sclp-reaches-new-1-year-low-at-6-00.html.
Scancell Company Profile (LON:SCLP)
Scancell Holdings plc engages in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer in the United Kingdom. The company's products include SCIB1, a plasmid DNA vaccine, which is in Phase I/II clinical trials for the treatment of melanoma; SCIB2 to treat lung cancer antigen; and Modi-1, which is in the pre-clinical development to treat triple negative breast cancer, ovarian cancer, and sarcoma.
Further Reading: Understanding each part of a balance sheet
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.